3Teijeira-Fernandez E,Eiras S,Shamagian LG,et al.Lower epicar-dial adipose tissue adiponectin in patients with metabolic syndrome[J].Cytokine,2011,54(2):185-190.
4Connell JM,MacKenzie SM,Freel EM,et al.A lifetime of aldoste-rone excess:long-term consequences of altered regulation of aldo-sterone production for cardiovascular function[J].Endocr Rev,2008,29(2):133-154.
5Arriza JL,Weinberger C,Cerelli G,et al.Cloning of human miner-alocorticoid receptor complementary DNA:structural and functionalkinship with the glucocorticoid receptor[J].Science,1987,237(4812):268-275.
6Grossmann C,Gekle M.New aspects of rapid aldosterone signaling[J].Mol Cell Endocrinol,2009,308(1/2):53-62.
7Funder JW.The nongenomic actions of aldosterone[J].EndocrRev,2005,26(3):313-321.
8Milliez P,Girerd X,Plouin PF,et al.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J].J Am Coll Cardiol,2005,45(8):1243-1248.
